Tag - RevBio

Sealing the Deal – Using Bone Glue to Treat Pain from Wisdom-Tooth Extractions

For many teens, having one or more wisdom teeth removed is a health milestone after the first third molar teeth come in at the very back of the mouth and there isn’t enough room for them. But with this milestone also often comes another one – their first exposure to opioids. “Of about 10 million wisdom-tooth extractions done in a year, about a third come with a prescription for an opioid,” says George Kay, D.M.D., Chief Scientific Officer at […]

RevBio Enters the Animal Health Market to Help Improve Canine Dental Care

As its first veterinary application, RevBio, Inc. announced that it has initiated a clinical study to validate the use of its innovative bone adhesive biomaterial to fill tooth extraction sockets in dogs in order to improve healing, maintain and support jaw thickness, and restore the structural stability which may help resist potential mandibular fractures. Read more >>

LaunchPad Medical Initiates its First European Clinical Study

LaunchPad Medical, Inc. announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study to examine the safety and efficacy of Tetranite®, the company’s bone adhesive biomaterial, to immediately stabilize dental implants following tooth extractions. Read more >>

LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant

LaunchPad Medical, Inc. announced that it has received follow-on support of up to $1.8 million from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center which was funded by the National Institute of Dental and Cranial Research (U24-DE029462) to improve the translation of promising tissue engineering and regenerative medicine technologies for dental, oral, and craniofacial clinical practice. Read more >>

LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures. Read more >>

Lowell-based company to start clinical trials on new dental glue

The way we replace teeth and do dental work may never be the same thanks to a new, synthetic glue being tested by Lowell-based LaunchPad Medical. LaunchPad Medical was recently given approval by the U.S. Food and Drug Administration to do a two-site, 20-patient clinical study to examine the safety and efficacy of the company’s bone adhesive biomaterial glue that could immediately stabilize those who have undergone dental implants for tooth extractions. Read more >>